Consumer in a Crunch? And “The Big Short’s” Steve Eisman on How He’s Positioned for the Rest of the Year 7/25/24
CNBC's "Fast Money"
00:00
Stock Price Pullback and Rotation in Healthcare Sector
The chapter delves into the recent stock price decline of Eli Lilly and Novo Nordisk following competition from Viking Therapeutics in the GLP1 treatment space. Discussion covers market valuation, competition impact on pricing, caution in investing in high valuation stocks like Lilly, and potential opportunities in trading XBI for takeover possibilities.
Play episode from 25:19
Transcript
